Search research articles
Contact Us
Filters
Showing results (111-120 of 114) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 114 results.
Journal of Translational Science
|
March 26, 2019
First-in-human phase 0 study of <sup>111</sup>In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging
K A Kurdziel, E Mena, Y McKinney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 1999
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry
T K Nikula, M R McDevitt, R D Finn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Blood
|
December 1, 1995
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac
T A Waldmann, J D White, J A Carrasquillo, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 114) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 114 results.
Journal of Translational Science
|
March 26, 2019
First-in-human phase 0 study of <sup>111</sup>In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging
K A Kurdziel, E Mena, Y McKinney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 1999
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry
T K Nikula, M R McDevitt, R D Finn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Blood
|
December 1, 1995
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac
T A Waldmann, J D White, J A Carrasquillo, et al.
Page
of 12